Literature DB >> 19083069

Does low molecular weight heparin impair anastomotic wound healing?

Emre Ergul1, Yigit Mehmet Ozgun, Gulten Kiyak, Gonca Barit Ozgun, Birol Korukluoglu, Ahmet Kusdemir.   

Abstract

BACKGROUND: Enoxaparin is an important molecule which had been using in prophylaxis and treatment of deep venous thrombosis. Also, it is showed that it prevents postsurgical peritoneal adhesions in rats. It is aimed to evaluate its effects on gastrointestinal wound healing.
METHODS: Thirty Wistar albino rats were divided into three groups as control, subcutan, and intraperitoneal enoxaparin groups. Left colon anastomoses were performed. On postoperative seventh day, anastomotic healing was evaluated by measuring anastomotic bursting pressure, tissue hydroxyproline levels, and histopathological examination.
RESULTS: The anastomotic bursting pressure was highest in subcutan enoxaparin group (p < 0.001), intraperitoneal enoxaparin group (p < 0.01) came the second, and the control group has the worst value. The hydroxyproline results were found nearly similar to the bursting pressure values (subcutan (p < 0.001) > intraperitoneal (p < 0.05) > control). Neovascularization in subcutan group (p < 0.001) has a statistically significant difference to other groups.
CONCLUSION: Enoxaparin did not interfere with colonic anastomotic resistance but improved the intestinal wound healing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083069     DOI: 10.1007/s11605-008-0771-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  24 in total

Review 1.  Effects of heparin on wound healing.

Authors:  L Galvan
Journal:  J Wound Ostomy Continence Nurs       Date:  1996-07       Impact factor: 1.741

Review 2.  The effects and uses of heparin in the care of burns that improves treatment and enhances the quality of life.

Authors:  M J Saliba
Journal:  Acta Chir Plast       Date:  1997

3.  Platelet-derived growth factor and epidermal growth factor play a major role in human colonic fibroblast repair activities.

Authors:  E Piazuelo; P Jimenez; A Lanas; A García; F Esteva; R Sainz
Journal:  Eur Surg Res       Date:  2000       Impact factor: 1.745

4.  Bursting strength of experimental colonic anastomoses. A methodological study.

Authors:  H Christensen; S Langfelt; S Laurberg
Journal:  Eur Surg Res       Date:  1993 Jan-Feb       Impact factor: 1.745

5.  Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats.

Authors:  Arie Levine; Gabriel Kenet; Rafael Bruck; Yona Avni; Ilana Avinoach; Hussein Aeed; Zipporah Matas; Magda David; Avner Yayon
Journal:  Pediatr Res       Date:  2002-05       Impact factor: 3.756

6.  Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients.

Authors:  G Jörneskog; K Brismar; B Fagrell
Journal:  Vasa       Date:  1993       Impact factor: 1.961

7.  Human endothelial cells are chemotactic to endothelial cell growth factor and heparin.

Authors:  V P Terranova; R DiFlorio; R M Lyall; S Hic; R Friesel; T Maciag
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

8.  Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients.

Authors:  Aykut Sifil; Cem Mermut; Yavuz Yenicerioglu; Caner Cavdar; Mukaddes Gumustekin; Ali Celik; Faize Yuksel; Taner Camsari
Journal:  Adv Perit Dial       Date:  2003

9.  Anastomotic healing in the rat colon: comparison between a radiological method, breaking strength and bursting pressure.

Authors:  Peter Månsson; Xiao Wei Zhang; Bengt Jeppsson; Henrik Thorlacius
Journal:  Int J Colorectal Dis       Date:  2002-04-16       Impact factor: 2.571

10.  The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts.

Authors:  A V Ferrao; R M Mason
Journal:  Biochim Biophys Acta       Date:  1993-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.